₹1,349.7
▼ -20.28 -1.48%
18 Jul 2026
NSE Listed · Pharmaceuticals
Zota Health Care Limited (ZOTA)
Volume: 33,361Avg Vol 1W: 45,629Avg Vol 1M: 79,93052W Range:₹1,026.2₹1,740
Key Ratios
Checked just nowMarket Cap₹4,674 Cr
Current Price₹1,349.7
Previous Close₹1,369.98
High / Low (52w)₹1,740 / ₹1,026.2
Volume33,361
Avg Vol (1W)45,629
Avg Vol (1M)79,930
Stock P/E—
Book Value₹200.24
Dividend Yield7%
ROE-10.66%
ROA-6.55%
Revenue (TTM)—
Revenue Growth62.32%
Profit Margin-13.73%
Total Debt₹5 Cr
Shares Outstanding3 Cr
Face Value₹10
EPS (TTM)₹0
P/B6.74
Debt / Equity0.75
50 DMA₹1,282.04
200 DMA₹1,370.88
Day change-1.48%
Price Chart
₹1,349.7▲ 11.61% · 1Y
2025-07-172026-07-17
20-day avg volume: 82K shares
Pros
- Pays a dividend yield of 7.0%.
- Company is almost debt-free.
- Revenue grew 62% YoY.
Cons
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹56 Cr | ₹67 Cr | ₹72 Cr | ₹97 Cr | ₹104 Cr | ₹129 Cr | ₹143 Cr | ₹163 Cr |
| EBITDA | ₹-9 Cr | ₹-10 Cr | ₹-17 Cr | ₹-11 Cr | ₹-10 Cr | ₹-11 Cr | ₹-21 Cr | ₹-15 Cr |
| Net Profit | ₹-13 Cr | ₹-12 Cr | ₹-19 Cr | ₹-13 Cr | ₹-14 Cr | ₹-16 Cr | ₹-29 Cr | ₹-14 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹56 Cr | ₹87 Cr | ₹97 Cr | ₹108 Cr | ₹133 Cr | ₹142 Cr | ₹182 Cr | ₹295 Cr |
| EBITDA | ₹7 Cr | ₹8 Cr | ₹4 Cr | ₹-1 Cr | ₹13 Cr | ₹-3 Cr | ₹-11 Cr | ₹-47 Cr |
| Net Profit | ₹4 Cr | ₹6 Cr | ₹3 Cr | ₹0 Cr | ₹9 Cr | ₹-6 Cr | ₹-14 Cr | ₹-56 Cr |
| EPS | 0 | 3.16 | 1.12 | -0.09 | 3.58 | -2.29 | -5.47 | -19.06 |
Balance Sheet
| Metric | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹40 Cr | ₹90 Cr | ₹88 Cr | ₹85 Cr | ₹139 Cr | ₹158 Cr | ₹228 Cr | ₹439 Cr |
| Total Liabilities | ₹22 Cr | ₹21 Cr | ₹20 Cr | ₹19 Cr | ₹49 Cr | ₹78 Cr | ₹138 Cr | ₹212 Cr |
| Equity | ₹18 Cr | ₹69 Cr | ₹69 Cr | ₹66 Cr | ₹90 Cr | ₹80 Cr | ₹90 Cr | ₹227 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹7 Cr | ₹-1 Cr | ₹7 Cr | ₹-1 Cr | ₹17 Cr | ₹0 Cr | ₹-4 Cr | ₹-46 Cr |
| Investing | ₹-1 Cr | ₹9 Cr | ₹-4 Cr | ₹4 Cr | ₹-27 Cr | ₹15 Cr | ₹-13 Cr | ₹-92 Cr |
| Financing | ₹-4 Cr | ₹-6 Cr | ₹-3 Cr | ₹-2 Cr | ₹14 Cr | ₹-14 Cr | ₹19 Cr | ₹145 Cr |
| Free Cash Flow | ₹7 Cr | ₹-1 Cr | ₹7 Cr | ₹-1 Cr | ₹17 Cr | ₹0 Cr | ₹-4 Cr | ₹-46 Cr |
Shareholding
Promoter 49.38% Institutions 14.92% Public 35.69%
Efficiency & Working Capital
ROCE-6.5%
Interest Coverage-4.3
Dividend Payout—
Debtor Days50 d
Inventory Days132 d
Payable Days53 d
Cash Conversion Cycle129 d
Working Capital Days182 d
Shareholding Details
As of 2026-03-31
Promoter49.4%
FII7.9%
DII7%
Institutions14.9%
Public35.7%
Promoter Pledge0.3%
No. of Shareholders14,005
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Aug 2024 | Aug 2024 | Sept 2024 | Dec 2024 | Feb 2025 | Mar 2025 | Apr 2025 | Apr 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 62.4% | 62.4% | 62.4% | 62% | 59.7% | 59.7% | 58.1% | 58.1% | 57.4% | 55.8% | 50.6% | 49.4% |
| FIIs | 0% | 0% | 0% | 0.2% | 1% | 0.9% | 3.6% | 3.6% | 3.8% | 3.5% | 8.1% | 7.9% |
| DIIs | 0.8% | 0% | 0% | 0% | 0% | 0% | 2.9% | 0% | 0% | 0.1% | 7.2% | 7% |
| Public | 36.8% | 37.6% | 37.6% | 37.7% | 39.2% | 39.4% | 35.4% | 38.3% | 38.8% | 40.6% | 34.1% | 35.7% |
| Promoter Pledge | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% |
| No. of Shareholders | 9,369 | 9,369 | 8,937 | 9,763 | 10,324 | 10,389 | 10,382 | 10,382 | 10,354 | 11,855 | 13,185 | 14,005 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Himansubhai Muktilal Zota | Shareholding of Promoter and Promoter Group | 9.1% | 31,35,580 |
| Ketankumar Chandulal Zota | Shareholding of Promoter and Promoter Group | 8.8% | 30,51,363 |
| Manukant Chandulal Zota | Shareholding of Promoter and Promoter Group | 6.3% | 21,72,070 |
| Kamlesh Rajanikant Zota | Shareholding of Promoter and Promoter Group | 5.8% | 19,91,103 |
| Asha Mukul Agrawal | Public Shareholding | 5.1% | 17,80,000 |
| Manishaben Kamleshkumar Zota | Shareholding of Promoter and Promoter Group | 4.1% | 14,32,966 |
| Valiant Mauritius Partners Offshore Limited | Public Shareholding | 3.4% | 11,70,949 |
| Rasilaben Manukantbhai Zota | Shareholding of Promoter and Promoter Group | 2.9% | 10,00,500 |
| Zota Ketankumar Chandulal | Shareholding of Promoter and Promoter Group | 2.8% | 9,81,756 |
| Varshaben Himanshubhai Zota | Shareholding of Promoter and Promoter Group | 2.6% | 8,99,146 |
| 3p India Equity Fund 1 | Public Shareholding | 2.3% | 7,88,012 |
| Anilaben Ketankumar Zota | Shareholding of Promoter and Promoter Group | 2.2% | 7,68,250 |
| Jainam Broking Limited | Public Shareholding | 2.2% | 7,53,073 |
| Mukul Mahavir Agrawal | Public Shareholding | 2.1% | 7,36,989 |
| Singularity Equity Fund I | Public Shareholding | 2% | 7,00,133 |
| Valiant Mauritius Partners Limited | Public Shareholding | 1.8% | 6,19,084 |
| Viren Manukant Zota (huf) (karta - Viren Manukant Zota) | Shareholding of Promoter and Promoter Group | 1.5% | 5,09,040 |
| Moxesh Ketanbhai Zota | Shareholding of Promoter and Promoter Group | 1.4% | 4,94,150 |
| Zota Manukant Chandulal Huf (karta - Zota Manukant Chandulal) | Shareholding of Promoter and Promoter Group | 0.6% | 2,06,767 |
| Dhara Mehta | Shareholding of Promoter and Promoter Group | 0.4% | 1,38,147 |
| Kenvi Zota | Shareholding of Promoter and Promoter Group | 0.3% | 95,000 |
| Kinjal Nikesh Mehta . | Shareholding of Promoter and Promoter Group | 0.2% | 52,004 |
| Heli Ritesh Shah | Shareholding of Promoter and Promoter Group | 0.1% | 32,040 |
| Krinal V Ankhad | Shareholding of Promoter and Promoter Group | 0.1% | 32,835 |
| Bhikhalal Chhotalal Doshi . | Shareholding of Promoter and Promoter Group | 0.1% | 19,646 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Zota Manukant Chandulal Huf (karta - Zota Manukant Chandulal) | 0 | 0% | 2026-03-31 |
| Ashokkumar Chandulal Zota (huf) (karta - Ashokkumar Chandulal Zota) | 0 | 0% | 2026-03-31 |
| Zota Ketankumar Chandulal | 0 | 0% | 2026-03-31 |
| Himanshu Muktilal Zota Huf (karta - Himanshu Muktilal Zota) | 0 | 0% | 2026-03-31 |
| Anilaben Ketankumar Zota | 0 | 0% | 2026-03-31 |
| Rasilaben Manukantbhai Zota | 0 | 0% | 2026-03-31 |
| Manukant Chandulal Zota | 0 | 0% | 2026-03-31 |
| Ashokkumar Chandulal Zota | 0 | 0% | 2026-03-31 |
| Varshaben Himanshubhai Zota | 0 | 0% | 2026-03-31 |
| Niralkumar Muktilal Zota | 0 | 0% | 2026-03-31 |
| Himansubhai Muktilal Zota | 0 | 0% | 2026-03-31 |
| Ketankumar Chandulal Zota | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ketankumar Zota | Chairman & Non Executive Dir. | 2025 |
| Moxesh Zota | Executive Director & MD | 2025 |
| Himanshu Zota | WTD & Executive Director | 2025 |
| Kamlesh Zota | WTD & Executive Director | 2025 |
| Viren Manukant Zota | WTD & Executive Director | 2025 |
| Laxmi Kant Sharma | Executive Director | 2025 |
| Varsaben Mehta | Independent Non Exe. Director | 2025 |
| Bhumi Maulik Doshi | Independent Non Exe. Director | 2025 |
| Vitrag Sureshkumar Modi | Independent Non Exe. Director | 2025 |
| Dhiren Prafulbhai Shah | Independent Non Exe. Director | 2025 |
| Jayshreeben Nileshkumar Mehta | Independent Non Exe. Director | 2025 |
| Dhaval Chandubhai Patwa | Independent Non Exe. Director | 2025 |
| Ashvin Variya | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing and marketing of Phar | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 35 | 29 | 29 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-22 | ₹1 (10%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 8 | 376 | 384 |
| 2025 | 0 | 0 | 0 | 2 | 284 | 286 |
| 2025 | 0 | 0 | 0 | 6 | 0 | 6 |
Company Information
Incorporated2000
ChairmanKetankumar Zota
AuditorPradeep K Singhi & Associates
Investor Email[email protected]
📍 Zota House 2/896 Hira Modi St, Sagrampura, Surat, Gujarat, 395002
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Zen Technologies LimitedZF Com Ve Ctr Sys Ind Ltd.Z F Steering Gear (I) Ltd.Zim Laboratories LimitedZodiac Energy LimitedZodiac Clothing Co.Ltd.Saraswati Comm (India) LimitedZ-Tech India LimitedZuari Agro Chemicals Ltd.Zuari Industries LimitedZydus Lifesciences Ltd.Zydus Wellness LimitedAll “Z” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search